Valbiotis S.A.S. is a French biotechnology company that specializes in innovative medical solutions designed to prevent and address major worldwide health challenges. At the heart of Valbiotis' mission is its dedication to developing plant-based solutions that demonstrate clinical effectiveness in the prevention of metabolic diseases such as Type 2 diabetes, cardiovascular disease, and other linked pathologies. By utilizing proprietary technology and collaborating with leading scientific institutions, Valbiotis develops products aimed at reducing the risk of these diseases before they become critical health problems. The company operates within the pharmaceutical and wellness sectors, with a focus on non-prescription markets that could alleviate the burden on healthcare systems globally. Significant in the health industry, Valbiotis plays a crucial role in pioneering preventative healthcare trends, fostering healthier lifestyles through science-backed phytotherapy. Since its inception, Valbiotis has built a strong portfolio of interim products that link plant-based active ingredients with rigorous clinical validation, influencing the landscape of preventative health solutions.